Synopsis
A year after Kerala reported India’s first Covid-19 case, the state continues to see a high number of active cases. But it has kept the death rate low.
Medical staff collect samples from people at a walk-in kiosk to test for coronavirus at Ernakulam Medical College in Kerala on April 6.
On January 30, 2020, health monitors at the Kochi airport in Kerala detected India’s first novel coronavirus patient a medical student returning from Wuhan, believed to be the origin of the contagion. The new virus was found to be much more efficient and faster in infecting humans than its predecessor Severe Acute Respiratory Syndrome (SARS) virus that had wreaked havoc across the world in 2002. While India’s first Covid-19 case was being reported, the global death toll from the disease had already touched 170.
TLLLF completes first cycle of certificate course in common mental disorders
TLLLF completes first cycle of certificate course in common mental disorders
29 January 2021 | News The first cohort, comprising 143 physicians, began in June 2020 and completed a comprehensive training programme split into five modules that ended last November
Source credit: Shutterstock
The Live Love Laugh Foundation (TLLLF) has announced the completion of the first cycle of the Certificate Course in Common Mental Disorders (CCCMD). The programme, delivered in partnership with the Public Health Foundation of India (PHFI) and Association of Healthcare Providers (India), trains primary care physicians to identify and manage common mental health disorders. TLLLF is the knowledge and grant partner, PHFI, the implementation partner and, AHPI, the strategic partner.
Why Budget 2021-2022 should increase allocations for child health and nutrition downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.
Tuesday, 9th February 2021 | 6:30 PM IST
LIVE ON FACEBOOK
In 1977, smallpox eradication lead to improved health systems, trained manpower to administer vaccines, infrastructure and systems to store vaccines and a network for surveillance of vaccine-preventable diseases. The lessons from this success were used universally to strengthen public healthcare, vaccination and develop a pool of public health professionals. In 1978, after it was declared free of smallpox, India launched the National Immunization Programme called the Expanded Programme of Immunization and since then has been one of the leading countries to introduce mass immunization measures for preventable diseases.
Although the Immunization programme in India has partially succeeded in reducing the burden of vaccine-preventable diseases; a significant proportion of them still exist. Moreover, there remains a wide gap in reported versus evaluated coverage. Now, with more than 16 lakh people already vaccinated in India and
Text Size:
A+
New Delhi: The Montreal Heart Institute (MHI) Saturday announced that the results of the COLCORONA clinical trial have proven the efficacy of colchicine drug in treating Covid-19.
A press release by MHI Friday said the results of the trial have shown that colchicine can reduce the risk of death or hospitalisation in Covid-19 patients by 21 per cent.
A widely-available low-cost drug, colchicine has been used for decades to treat gout and Behçet’s disease, an inflammatory disorder that affects different parts of the body. The COLCORONA trial was conducted in several countries including Canada and the US to determine the effects of the drug in reducing complications associated with the coronavirus infection.